von Willebrand factor helps platelets attach to damaged blood vessels and form clots to stop bleeding. When this protein is missing or significantly reduced, affected dogs may experience prolonged or uncontrolled bleeding.
vWD3-2 is considered one of the most serious forms of von Willebrand Disease because affected dogs often have extremely low levels of functional von Willebrand factor. Even minor injuries, routine surgeries, or dental procedures can result in excessive bleeding. In severe cases, spontaneous bleeding may occur without any obvious injury, creating potentially life-threatening situations if immediate veterinary care is not provided.
Dogs affected by vWD3-2 may show symptoms such as frequent nosebleeds, bleeding gums, easy bruising, blood in the urine or stool, prolonged bleeding after cuts, and excessive bleeding following surgeries, vaccinations, nail trimming, or tooth eruption. Some puppies may develop signs at a young age, while others may only be diagnosed after an unexpected bleeding episode during a medical procedure or injury. Female dogs may also experience excessive bleeding during heat cycles or after giving birth.
von Willebrand Disease (vWD3-2) is inherited in an autosomal recessive pattern. This means a dog must inherit two copies of the mutated gene — one from each parent — to be genetically affected. Dogs with only one copy of the mutation are known as carriers. Carrier dogs typically do not show severe symptoms but can still pass the mutation to future generations. If two carrier dogs are bred together, there is a 25% chance of producing affected puppies, a 50% chance of producing carrier puppies, and a 25% chance of producing genetically clear puppies.
The vWD3-2 genetic test identifies whether a dog is clear, a carrier, or affected by the mutation associated with this bleeding disorder. Testing is simple, safe, and usually performed using a cheek swab or blood sample. The collected DNA sample is analyzed in a laboratory to determine the dog’s genetic status. Because symptoms may not always be obvious, genetic testing is one of the most reliable methods for identifying dogs at risk.
Genetic screening is especially important for responsible breeding programs. Since carriers may appear completely healthy, breeding without testing can unintentionally spread the mutation within a breed population. By testing breeding dogs before mating, breeders can make informed decisions that reduce the risk of producing affected puppies while supporting long-term breed health and genetic diversity.
Although there is currently no cure for von Willebrand Disease (vWD3-2), affected dogs can often live good-quality lives with careful management and veterinary supervision. Preventive care focuses on minimizing injury risks and preparing for situations where bleeding may occur. In emergencies or during surgery, blood transfusions, plasma therapy, or clotting support treatments may be required. Veterinarians may also recommend avoiding medications that interfere with normal blood clotting.
Early diagnosis through genetic testing allows owners and veterinarians to take appropriate precautions before medical procedures and monitor affected dogs more closely. Understanding a dog’s genetic status helps improve health management and reduces the risk of unexpected bleeding complications.
Testing for von Willebrand Disease (vWD3-2) demonstrates a commitment to responsible dog ownership, ethical breeding, and the long-term health and welfare of future generations of dogs.
